![7-chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile](https://static.cymitquimica.com/cas-image/343070-7-chloro-9-oxo-9h-indeno-12-b-pyrazine-23-dicarbonitrile.png)
CAS 924296-39-9: 7-chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile
Formula:C13H3ClN4O
InChI:InChI=1/C13H3ClN4O/c14-6-1-2-7-8(3-6)13(19)12-11(7)17-9(4-15)10(5-16)18-12/h1-3H
- Sinonimi:
- 9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 7-chloro-9-oxo-
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile REF: IN-DA0034E9CAS: 924296-39-9 | 98% | Prezzo su richiesta | Lun 03 Mar 25 |
 | HBX 41108 REF: TM-T21527CAS: 924296-39-9 | 95.63% | 51,00 €~893,00 € | Lun 10 Mar 25 |
 | HBX 41108 REF: 3D-FC145339CAS: 924296-39-9 | Min. 95% | 381,00 €~1.033,00 € | Lun 14 Apr 25 |
![7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile](https://static.cymitquimica.com/products/IN/thumb/DA0034E9.jpg)
7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile
CAS:924296-39-9
Formula:
C13H3ClN4O
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
266.6421
Ref: IN-DA0034E9
| 5mg | 274,00 € | ||
| 10mg | 576,00 € | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 03 Marzo 2025
HBX 41108
CAS:924296-39-9
HBX 41108: non-competitive, reversible USP7 inhibitor; IC50: 424nM; blocks USP7-p53 deubiquitination; IC50: 0.8μM.
Formula:
C13H3ClN4O
Purezza:
95.63%
Colore e forma:
Solid
Peso molecolare:
266.64
Ref: TM-T21527
| 1mg | 51,00 € | ||
| 2mg | 74,00 € | ||
| 5mg | 111,00 € | ||
| 10mg | 180,00 € | ||
| 25mg | 424,00 € | ||
| 50mg | 627,00 € | ||
| 100mg | 893,00 € |
Consegna stimata in Stati Uniti, il Lunedì 10 Marzo 2025
HBX 41108
CAS:924296-39-9
Inhibitor of ubiquitin-specific protease USP7
Formula:
C13H3ClN4O
Purezza:
Min. 95%
Peso molecolare:
266.64 g/mol
Ref: 3D-FC145339
| 5mg | 381,00 € | ||
| 10mg | 576,00 € | ||
| 25mg | 1.033,00 € |
Consegna stimata in Stati Uniti, il Lunedì 14 Aprile 2025
